Cure8 research brief
This study addresses whether removing the appendix changes long-term UC outcomes. People with UC or their clinicians might expect surgery to alter disease course; these real-world data suggest it generally does not for the measured outcomes.
Adults with ulcerative colitis, gastroenterologists, colorectal surgeons, and researchers studying surgical influences on IBD course.
This multicenter observational study used electronic health-record data to compare adults with ulcerative colitis who had an appendectomy either before or after UC diagnosis to matched controls.
The main outcome was a 5-year composite of oral or IV corticosteroid use or colectomy; overall the authors found no clear association between appendectomy timing and the composite outcome, colectomy, or initiation of advanced therapy.
The analysis did note a lower rate of IV steroid use among those who had appendectomy before UC diagnosis, and a subgroup signal of reduced advanced-therapy starts in 18–40-year-olds after appendectomy performed following UC diagnosis.
The paper reports adjusted hazard ratios and used propensity-score matching to reduce confounding, but as an observational, retrospective EHR-based study it cannot prove causation. The findings apply to the populations and definitions used (TriNetX U.S. Collaborative Network, 2010–2024) and may not generalize to all settings.
If you or a clinician are considering appendectomy for UC-related reasons, this study does not provide evidence that appendectomy (before or after diagnosis) improves long-term UC outcomes such as preventing colectomy or reducing steroid or advanced-therapy needs; decisions should be individualized and based on surgical indications and clinical judgment.
This is a retrospective observational study using EHR data and propensity matching; such designs can reduce but not eliminate confounding. Subgroup findings (reduced IV steroid use and a younger age group signal) are hypothesis-generating and would need confirmation in other datasets or prospective studies.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with ulcerative colitis who have had colectomy can rarely develop inflammation of the small intestine and high-output stomas that are hard to control.
For patients and clinicians facing steroid- and infliximab-refractory acute severe ulcerative colitis, upadacitinib may be a third-line medical option that can produce rapid symptom and CRP improvement and allow some...
The review examines whether removing the appendix could change the course of ulcerative colitis — a potential surgical option that might lower colectomy or hospitalization risk in some scenarios but also carries...
